Ovid Therapeutics Inc. (OVID) Operating income 2016–2025
Ovid Therapeutics Inc. (OVID) annual operating income history from SEC filings — each fiscal year as reported.
-$42.4MFY2025 · since FY2016: -$22.5M → -$42.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$42.4M | +31.4% |
| FY2024 | -$61.9M | -4.4% |
| FY2023 | -$59.3M | -6.7% |
| FY2022 | -$55.5M | -144.7% |
| FY2021 | $124.2M | +252.5% |
| FY2020 | -$81.4M | -32.6% |
| FY2019 | -$61.4M | -16.0% |
| FY2018 | -$52.9M | +18.6% |
| FY2017 | -$65.0M | -188.5% |
| FY2016 | -$22.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More OVID financial trends
OVID RevenueOVID Net incomeOVID Net marginOVID Gross profitOVID Gross marginOVID Operating marginOVID Operating cash flowOVID Free cash flowOVID Capital expendituresOVID Return on equityOVID Stock buybacksOVID Dividends paidOVID Total assetsOVID Total liabilitiesOVID Shareholders’ equityOVID overview →